RAD receives IND approval from US FDA for Betabart (RV-01) – The Golden Capital

RAD receives IND approval from US FDA for Betabart (RV-01)

Investing

July 28, 2025

Share It:

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Copyright © 2025 thegoldencapital.ca. All Right Reserved.